Cedric Hermans: This Should Be a Great Discussion — Do Not Hesitate to Join Us
Cedric Hermans, Head of Haemophilia Centre at the Cliniques Universitaires Saint-Luc in Brussels, reposted from Journal of Thrombosis and Haemostasis (JTH) on LinkedIn:
”This should be a great discussion
Do not hesitate joining us.”
Quoting Journal of Thrombosis and Haemostasis (JTH)‘s post:
”Did you hear the news? Our sister RPTH Journal has an exciting Research Recap coming up next week! Join to hear from Robert Sidonio, MD,MSc, author of the recently published RPTH article: “Activated prothrombin complex concentrate in patients receiving emicizumab prophylaxis: from evidence to clinical practice.”
Cedric Hermans MD PhD FRCP (Lon,Edin), author of related commentary on the topic, will also give a brief response. They will be led in a conversation with moderator Michael Makris, the RPTH Editor-in-Chief.
Excited? So are we! Read before you watch:
Secure your spot here.”
Title1: Activated prothrombin complex concentrate in patients receiving emicizumab prophylaxis: from evidence to clinical practice
Authors: Robert F. Sidonio, Jr., Guy Young, Carmen Escuriola Ettingshausen, Johnny Mahlangu, Margareth C. Ozelo, Alok Srivastava, Jerzy Windyga, Hye–Youn Lee, Aurelia Lelli, Steven W. Pipe
Title2: Cautious use of activated prothrombin complex concentrate in patients receiving emicizumab: new evidence and clinical considerations
Author: Cedric Hermans
Stay updated on all scientific advances in the field of bleeding disorders with Hemostasis Today.
-
Oct 25, 2025, 10:13Meet the 2025 WSO Award Winners for Their Extensive Contributions to Stroke Science
-
Oct 25, 2025, 09:53Aakanksha A Shares The 1st Post in ASH 12-Part Microlearning Series
-
Oct 25, 2025, 09:22Alessandro Bufi Presented SAIDE Project at World Stroke Congress 2025
-
Oct 25, 2025, 09:06A Short Story About a Platelet Named Pippa from Krista Goerger
-
Oct 25, 2025, 08:31Maxime Dely: What if We Could Leukoreduce Without a Filter?
-
Oct 24, 2025, 12:08Julián Alejandro Rivillas Compares Tenecteplase to Low-dose Alteplase: TRACE-5 Interim Phase II Results
-
Oct 24, 2025, 12:03Melissa Glasner on Integration of Gene Therapy Into Hemophilia Care
-
Oct 24, 2025, 11:41Yaping Zhang on Platelet Adhesion Receptors
-
Oct 24, 2025, 11:37Omid Jafari and Colleagues Present the VTE-BERT Natural Language Processing Model
-
Oct 24, 2025, 11:34Insights on IV Thrombolysis and Mechanical Thrombectomy from Benjamin Maier and Colleagues
-
Oct 23, 2025, 09:57Arun V. J: Artificial Blood Is Closer Than You Think
-
Oct 23, 2025, 07:11Sebastien Lobet Presented the ACTIVLIM-Hemo Scale
-
Oct 23, 2025, 07:05Syed Ehsan Shah on Advantages of Werfen HemoCell Automation
-
Oct 22, 2025, 08:25Johanna Nystedt: Not Every Day We Can Release a New Blood Product to Meet An Unmet Medical Need!
-
Oct 21, 2025, 06:58Arno Nierich: How Caffeine Affects Red Blood Cells and Blood Storage
-
Oct 25, 2025, 09:32Sylaja Pn Wins 2025 WSO Presidential Award
-
Oct 25, 2025, 08:21Courtney Lawrence: Listen. Empower. Deliver. Save Lives!
-
Oct 25, 2025, 08:14Hema Tallman on Incredible Opportunity to Participate in the PPTA 2025 Meetings
-
Oct 24, 2025, 11:28Louise Bannon and Thomas Reiser Thank World Thrombosis Day Supporters Around The World
-
Oct 24, 2025, 10:48Melanie Daniel Congratulates Mickael Rosa and Antoine Rauch on Winning Bernd R. Binder Prize